These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2400991)

  • 41. Membrane-associated cathepsin L: a role in metastasis of melanomas.
    Rozhin J; Wade RL; Honn KV; Sloane BF
    Biochem Biophys Res Commun; 1989 Oct; 164(1):556-61. PubMed ID: 2803319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells.
    Honn KV; Timár J; Rozhin J; Bazaz R; Sameni M; Ziegler G; Sloane BF
    Exp Cell Res; 1994 Sep; 214(1):120-30. PubMed ID: 7521840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role for cathepsin B and cystatins in tumor growth and progression.
    Sloane BF; Rozhin J; Robinson D; Honn KV
    Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():193-8. PubMed ID: 2400581
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of cysteine proteinase inhibitors on murine B16 melanoma cell invasion in vitro.
    Sever N; Filipic M; Brzin J; Lah TT
    Biol Chem; 2002 May; 383(5):839-42. PubMed ID: 12108549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cystatin C and cathepsin B in human colon carcinoma: expression by cell lines and matrix degradation.
    Corticchiato O; Cajot JF; Abrahamson M; Chan SJ; Keppler D; Sordat B
    Int J Cancer; 1992 Oct; 52(4):645-52. PubMed ID: 1399147
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein-kinase-C inhibitor calphostin C reduces B16 amelanotic melanoma cell adhesion to endothelium and lung colonization.
    Liu B; Renaud C; Nelson KK; Chen YQ; Bazaz R; Kowynia J; Timar J; Diglio CA; Honn KV
    Int J Cancer; 1992 Aug; 52(1):147-52. PubMed ID: 1379995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimetastatic activity of adriamycin in combinations with proteinase inhibitors in mice.
    Leto G; Tumminello FM; Gebbia N; Woynarowska B; Bernacki RJ
    Anticancer Res; 1990; 10(1):265-9. PubMed ID: 2334138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activity of cysteine protease inhibitors in human brain tumors.
    Berdowska I; Siewiński M; Zarzycki-Reich A; Jarmułowicz J; Noga L
    Med Sci Monit; 2001; 7(4):675-9. PubMed ID: 11433194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cathepsin B and its endogenous inhibitors: the role in tumor malignancy.
    Sloane BF; Moin K; Krepela E; Rozhin J
    Cancer Metastasis Rev; 1990 Dec; 9(4):333-52. PubMed ID: 2097084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Separation of high and low metastatic subpopulations from solid tumors by centrifugal elutriation.
    Onoda JM; Nelson KK; Grossi IM; Umbarger LA; Taylor JD; Honn KV
    Proc Soc Exp Biol Med; 1988 Feb; 187(2):250-5. PubMed ID: 2829227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sp1 regulates cathepsin B transcription and invasiveness in murine B16 melanoma cells.
    Szpaderska AM; Silberman S; Ahmed Y; Frankfater A
    Anticancer Res; 2004; 24(6):3887-91. PubMed ID: 15736427
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level.
    Spiess E; Brüning A; Gack S; Ulbricht B; Spring H; Trefz G; Ebert W
    J Histochem Cytochem; 1994 Jul; 42(7):917-29. PubMed ID: 8014475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical relevance of cathepsin B-like enzyme activity and cysteine proteinase inhibitor in melanocytic tumours.
    Yoshii A; Kageshita T; Tsushima H; Ono T
    Arch Dermatol Res; 1995; 287(2):209-13. PubMed ID: 7763093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cathepsins in bleomycin-induced lung injury in rat.
    Koslowski R; Knoch K; Kuhlisch E; Seidel D; Kasper M
    Eur Respir J; 2003 Sep; 22(3):427-35. PubMed ID: 14516131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of cathepsin B activity in human breast cancer tissue by cysteine peptidase inhibitor isolated from human placenta: immunohistochemical and biochemical studies.
    Saleh Y; Siewiński M; Sebzda T; Jeleń M; Ziółkowski P; Gutowicz J; Gryboś M; Pawelec M
    Folia Histochem Cytobiol; 2003; 41(3):161-7. PubMed ID: 13678335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cathepsin B: association with plasma membrane in metastatic tumors.
    Sloane BF; Rozhin J; Johnson K; Taylor H; Crissman JD; Honn KV
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2483-7. PubMed ID: 3458210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gold nanoparticles-based colorimetric assay for cathepsin B activity and the efficiency of its inhibitors.
    Kim CJ; Lee DI; Kim C; Lee K; Lee CH; Ahn IS
    Anal Chem; 2014 Apr; 86(8):3825-33. PubMed ID: 24673125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor cell membrane cathepsin B.
    Moin K; Cao L; Day NA; Koblinski JE; Sloane BF
    Biol Chem; 1998; 379(8-9):1093-9. PubMed ID: 9792442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imbalance between cathepsin-B and cysteine proteinase-inhibitors is of prognostic-significance in human lung-cancer.
    Knoch H; Werle B; Ebert W; Spiess E
    Int J Oncol; 1994 Jul; 5(1):77-85. PubMed ID: 21559560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The current stage of cathepsin B inhibitors as potential anticancer agents.
    Kos J; Mitrović A; Mirković B
    Future Med Chem; 2014 Jul; 6(11):1355-71. PubMed ID: 25163003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.